Clinical Trial Update: Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial evaluated Myobloc (rimabotulinumtoxinB) for reducing drooling in patients with Amyotrophic Lateral Sclerosis, and the study has completed Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Sialorrhea

Drugs mentioned

• MYOBLOC (rimabotulinumtoxinB)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Amyotrophic Lateral Sclerosis, Sialorrhea | Phase 2, Phase 3 | Status: COMPLETED